I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
Etidronate disodium is used as a bisphosphonate bone resorption inhibitor. Etidronic acid is used as a calcium regulator. Etidronic acid is a bisphosphonate antiresorptive agent.
RP Heaney.; PD Saville. Etidronate disodium in postmenopausal osteoporosis. Clinical pharmacology and therapeutics. 1976, 20(5), 593-604.
N Shiraishi.; K Kitamura.;T Miyoshi.; M Adachi. Successful treatment of a patient with severe calcific uremic arteriolopathy (calciphylaxis) byetidronate disodium. American Journal of Kidney Diseases. 2006, 48(1), 151-154.
Hazard Statements: H302
Harmful if swallowed.
Precautionary Statements: P264-P270-P301+P312a-P330-P501a
Wash thoroughly after handling. Do not eat, drink or smoke when using this product. IF SWALLOWED: Rinse mouth. Dispose of contents/container in accordance with local/regional/national/international regulations.